Search research articles
Contact Us
Filters
Showing results (371-380 of 386) with videos related to
Page
of 39
Sort By:
The Journal of Clinical Investigation
|
October 31, 2017
HIV-antibody complexes enhance production of type I interferon by plasmacytoid dendritic cells
Rebecca T Veenhuis, Zachary T Freeman, Jack Korleski, et al.
Antimicrobial Agents and Chemotherapy
|
January 29, 2014
Community-onset Escherichia coli infection resistant to expanded-spectrum cephalosporins in low-prevalence countries
Benjamin A Rogers, Paul R Ingram, Naomi Runnegar, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
July 20, 2007
Effects of a monoclonal antibody raised against nerve growth factor on skeletal pain and bone healing after fracture of the C57BL/6J mouse femur
Nathan J Koewler, Katie T Freeman, Ryan J Buus, et al.
Bone
|
September 22, 2010
Sustained blockade of neurotrophin receptors TrkA, TrkB and TrkC reduces non-malignant skeletal pain but not the maintenance of sensory and sympathetic nerve fibers
Joseph R Ghilardi, Katie T Freeman, Juan M Jimenez-Andrade, et al.
Cancer Discovery
|
September 30, 2016
TGFβ1-Mediated SMAD3 Enhances PD-1 Expression on Antigen-Specific T Cells in Cancer
Benjamin V Park, Zachary T Freeman, Ali Ghasemzadeh, et al.
Veterinary Pathology
|
November 19, 2020
Development of Mast Cell and Eosinophil Hyperplasia and HLH/MAS-Like Disease in NSG-SGM3 Mice Receiving Human CD34+ Hematopoietic Stem Cells or Patient-Derived Leukemia Xenografts
Laura J Janke, Denise M Imai, Heather Tillman, et al.
Journal of Medicinal Chemistry
|
October 1, 2021
Functional Mixture-Based Positional Scan Identifies a Library of Antagonist Tetrapeptide Sequences (LAtTeS) with Nanomolar Potency for the Melanocortin-4 Receptor and Equipotent with the Endogenous AGRP(86-132) Antagonist
Mark D Ericson, Skye R Doering, Courtney M Larson, et al.
Journal of Medicinal Chemistry
|
April 29, 2017
Discovery of Mixed Pharmacology Melanocortin-3 Agonists and Melanocortin-4 Receptor Tetrapeptide Antagonist Compounds (TACOs) Based on the Sequence Ac-Xaa<sup>1</sup>-Arg-(pI)DPhe-Xaa<sup>4</sup>-NH<sub>2</sub>
Skye R Doering, Katie T Freeman, Sathya M Schnell, et al.
Translational Psychiatry
|
May 20, 2015
Neurocognitive dysfunction and pharmacological intervention using guanfacine in a rhesus macaque model of self-injurious behavior
Z T Freeman, K A Rice, P L Soto, et al.
Pain
|
August 19, 2007
Nerve growth factor sequestering therapy attenuates non-malignant skeletal pain following fracture
Juan M Jimenez-Andrade, Carl D Martin, Nathan J Koewler, et al.
Page
of 39
Search research articles
Search
Showing results (371-380 of 386) with videos related to
Sort By:
Page
of 39
The Journal of Clinical Investigation
|
October 31, 2017
HIV-antibody complexes enhance production of type I interferon by plasmacytoid dendritic cells
Rebecca T Veenhuis, Zachary T Freeman, Jack Korleski, et al.
Antimicrobial Agents and Chemotherapy
|
January 29, 2014
Community-onset Escherichia coli infection resistant to expanded-spectrum cephalosporins in low-prevalence countries
Benjamin A Rogers, Paul R Ingram, Naomi Runnegar, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
July 20, 2007
Effects of a monoclonal antibody raised against nerve growth factor on skeletal pain and bone healing after fracture of the C57BL/6J mouse femur
Nathan J Koewler, Katie T Freeman, Ryan J Buus, et al.
Bone
|
September 22, 2010
Sustained blockade of neurotrophin receptors TrkA, TrkB and TrkC reduces non-malignant skeletal pain but not the maintenance of sensory and sympathetic nerve fibers
Joseph R Ghilardi, Katie T Freeman, Juan M Jimenez-Andrade, et al.
Cancer Discovery
|
September 30, 2016
TGFβ1-Mediated SMAD3 Enhances PD-1 Expression on Antigen-Specific T Cells in Cancer
Benjamin V Park, Zachary T Freeman, Ali Ghasemzadeh, et al.
Veterinary Pathology
|
November 19, 2020
Development of Mast Cell and Eosinophil Hyperplasia and HLH/MAS-Like Disease in NSG-SGM3 Mice Receiving Human CD34+ Hematopoietic Stem Cells or Patient-Derived Leukemia Xenografts
Laura J Janke, Denise M Imai, Heather Tillman, et al.
Journal of Medicinal Chemistry
|
October 1, 2021
Functional Mixture-Based Positional Scan Identifies a Library of Antagonist Tetrapeptide Sequences (LAtTeS) with Nanomolar Potency for the Melanocortin-4 Receptor and Equipotent with the Endogenous AGRP(86-132) Antagonist
Mark D Ericson, Skye R Doering, Courtney M Larson, et al.
Journal of Medicinal Chemistry
|
April 29, 2017
Discovery of Mixed Pharmacology Melanocortin-3 Agonists and Melanocortin-4 Receptor Tetrapeptide Antagonist Compounds (TACOs) Based on the Sequence Ac-Xaa<sup>1</sup>-Arg-(pI)DPhe-Xaa<sup>4</sup>-NH<sub>2</sub>
Skye R Doering, Katie T Freeman, Sathya M Schnell, et al.
Translational Psychiatry
|
May 20, 2015
Neurocognitive dysfunction and pharmacological intervention using guanfacine in a rhesus macaque model of self-injurious behavior
Z T Freeman, K A Rice, P L Soto, et al.
Pain
|
August 19, 2007
Nerve growth factor sequestering therapy attenuates non-malignant skeletal pain following fracture
Juan M Jimenez-Andrade, Carl D Martin, Nathan J Koewler, et al.
Page
of 39